Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the <scp>AMBORA</scp> Cohort: An Analysis of Real‐World Data
Year: 2025
Type: article
Language: en
Topic: Advanced Breast Cancer Therapies
Authors and affiliations:
raw_author_name: Michael I. Sponfeldner
raw_affiliation_strings: Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Pauline Dürr
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
Pharmacy Department Erlangen University Hospital and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Phyllis Lensker
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
Pharmacy Department Erlangen University Hospital and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Katja Gessner
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Lisa Cuba
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
Pharmacy Department Erlangen University Hospital and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Rainer Fietkau
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Radiation Oncology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Markus F. Neurath
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Medicine 1, Gastroenterology, Pneumology and Endocrinology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Bernd Wullich
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Urology and Paediatric Urology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Marianne Pavel
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Medicine 1, Gastroenterology, Pneumology and Endocrinology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Carola Berking
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Dermatology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Matthias W. Beckmann
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Obstetrics and Gynaecology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Andreas Mackensen
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
Department of Internal Medicine 5, Hematology and Oncology Uniklinikum Erlangen and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Frank Dörje
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
FAU NeW – Research Center New Bioactive Compounds Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
Pharmacy Department Erlangen University Hospital and Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
raw_author_name: Martin F. Fromm
raw_affiliation_strings: Bavarian Cancer Research Center (BZKF)  Erlangen Germany
Comprehensive Cancer Center Erlangen‐EMN Uniklinikum Erlangen  Erlangen Germany
FAU NeW – Research Center New Bioactive Compounds Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany
Institute of Experimental and Clinical Pharmacology and Toxicology Friedrich‐Alexander‐Universität Erlangen‐Nürnberg  Erlangen Germany